Antisoma Plc has appointed Michael Lewis as a non-executive director with immediate effect. Mr Lewis is currently president for Europe, the Middle East and Africa for the medical device company, Gambro. He was also head of global marketing for the same concern. In these positions he was responsible for $1.3 billion in sales and 1,000 staff. Before joining Gambro in 2002, he was chief executive officer and managing director of Sybron, a specialist dental business based in Switzerland.
Antisoma’s chairman, Barry Price, said that Mr Lewis’s experience in international healthcare marketing will be invaluable to the UK company as it moves in the coming years from drug development to commercialising its own products.
Source
Antisoma Plc press release, 14 July 2008
Copyright 2008 Evernow Publishing Ltd